BioNTech SE (BNTX) Interest Expenses (2018 - 2026)

BioNTech SE has disclosed Interest Expenses across 9 years of filings, most recently posting -$9.2 million for Q2 2026.

• In Q2 2026, Interest Expenses fell 15.89% year-over-year to -$9.2 million; the TTM figure through Jun 2026 stood at -$56.6 million (up 13.96% YoY), while the FY2025 annual figure was $81.3 million, up 177.5% from the prior year.
• Interest Expenses came in at -$9.2 million for Q2 2026 at BioNTech SE, up from -$13.1 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of -$1.4 million in Q2 2023 to a low of -$162.3 million in Q4 2022.
• Average Interest Expenses over 5 years is -$21.0 million, with a median of -$8.4 million recorded in 2024.
• The largest YoY upside for Interest Expenses was 97.08% in 2022 against a maximum downside of 6656.8% in 2022.
• Over 5 years, Interest Expenses stood at -$162.3 million in 2022, then jumped by 83.3% to -$27.1 million in 2023, then surged by 50.34% to -$13.5 million in 2024, then soared by 63.69% to -$4.9 million in 2025, then plunged by 87.82% to -$9.2 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were -$9.2 million in Q2 2026, -$13.1 million in Q1 2026, and -$4.9 million in Q4 2025.